Home
About
Technology
Pipeline
Partners
Investors
News + Resources
- News
- Resource Library
Careers
Menu Menu

Allied Post Video Form

Optejet: Novel Solution for Topical Drug Administration | MydCombi Instructions for Use

Please complete the form below and share any questions you may have for Josh Dragon

Your Name(Required)

Your Email(Required)

Questions for Josh Dragon | Optejet: Novel Solution for Topical Drug Administration | MydCombi Instructions for Use

Recent Posts

Eyenovia To Feature Its Suite Of Commercial Products And The Optejet® Dispenser At Upcoming National Eyecare Meetings April 4, 2024
NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals March 13, 2024
Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th March 11, 2024

Pipeline and Technology

MydCombi (Mydriasis)
Clobetasol Propionate
MicroPine (Myopia)
Apersure (Presbyopia)
Technology

Corporate Address

Eyenovia, Inc.
295 Madison Avenue
Suite 2400
New York, NY 10017
admin@eyenovia.com

Copyright © 2023 Eyenovia, Inc. All rights reserved.

Twitter
Facebook
LinkedIn

Contact
Safe Harbor
Privacy Policy
Terms of Use
CA Declaration of Compliance